{
  "id": "Ex099",
  "type": "Example",
  "informationId": {
    "id": "CritAssess378",
    "type": "CriterionAssessment",
    "explanation": "Another variant at the same residue (Lys483Asn) was identified as a de novo variant in an individual with features of a Noonan spectrum disorder (LMM unpublished data). The other variant: NM_004333.4(BRAF):c.1449A>C (p.Lys483Asn) is classified as likely pathogenic by LMM for Rasopathy.",
    "criterion": {
      "id": "PM5",
      "type": "Criterion",
      "description": "Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before",
      "shortDescription": "Novel missense at same amino acid as known pathogenic missense",
      "defaultStrength": {
        "id": "CG-evidence-strength:pm"
      }
    },
    "variant": {
      "id": "CanAll125",
      "type": "CanonicalAllele",
      "preferredCtxAllele": "CtxAll131",
      "identifier": "http://reg.genome.network/allele/CA280055"
    },
    "condition": [
      {
        "id": "MendCond049",
        "type": "MendelianCondition",
        "explanation": "Rasopathy",
        "disease": [
          {
            "id": "Orphanet:98733",
            "type": "Coding",
            "code": "98733",
            "system": "http://www.orpha.net/",
            "display": "Noonan syndrome and Noonan-related syndrome"
          }
        ],
        "name": "Rasopathy"
      }
    ],
    "outcome": {
      "id": "CG-criterion-outcome:met",
      "type": "Coding",
      "code": "met",
      "system": "http://clinicalgenome.org/datamodel/criterion-assertion-outcome/",
      "display": "Met"
    },
    "evidence": [
      {
        "id": "EvLn130",
        "type": "EvidenceLine",
        "explanation": "EvLn130",
        "information": [
          {
            "id": "VarInterp060",
            "type": "VariantInterpretation",
            "explanation": "The Lys483Asn variant in BRAF has not been previously reported in the literature, but has been identified as a de novo variant in one proband in our laboratory. In addition, this residue is highly conserved across evolutionarily distinct species and computational analyses (PolyPhen2, SIFT, AlignGVGD) predict that this variant will impact the normal function of BRAF. It should be noted that the sensitivity and specificity of these computational programs has not been determined by our laboratory. Therefore, this variant is likely to be pathogenic.",
            "variant": {
              "id": "CanAll127",
              "type": "CanonicalAllele",
              "preferredCtxAllele": "CtxAll133",
              "identifier": "http://reg.genome.network/allele/CA273507"
            },
            "condition": [
              {
                "id": "MendCond049",
                "type": "MendelianCondition",
                "explanation": "Rasopathy",
                "disease": [
                  {
                    "id": "Orphanet:98733",
                    "type": "Coding",
                    "code": "98733",
                    "system": "http://www.orpha.net/",
                    "display": "Noonan syndrome and Noonan-related syndrome"
                  }
                ],
                "name": "Rasopathy"
              }
            ],
            "clinicalSignificance": {
              "id": "LN:LA26332-9",
              "type": "Coding",
              "code": "LA26332-9",
              "system": "http://loinc.org/",
              "display": "Likely Pathogenic"
            },
            "contribution": [
              {
                "type": "Contribution",
                "agent": {
                  "id": "Agent010",
                  "type": "Agent",
                  "name": "ACME Molecular Lab"
                },
                "onDate": "6/12/2011 9:00 AM",
                "role": {
                  "id": "CC420",
                  "type": "CodeableConcept",
                  "coding": [
                    {
                      "id": "CG-contributory-role:interpreter",
                      "type": "Coding",
                      "code": "interpreter",
                      "system": "http://clinicalgenome.org/datamodel/contributory-role/",
                      "display": "interpreter"
                    }
                  ]
                }
              }
            ]
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent010",
          "type": "Agent",
          "name": "ACME Molecular Lab"
        },
        "onDate": "6/10/2011 1:45 PM",
        "role": {
          "id": "CC419",
          "type": "CodeableConcept",
          "coding": [
            {
              "id": "CG-contributory-role:assessor",
              "type": "Coding",
              "code": "assessor",
              "system": "http://clinicalgenome.org/datamodel/contributory-role/",
              "display": "assessor"
            }
          ]
        }
      }
    ]
  },
  "index": 4,
  "author": "Marina DiStefano",
  "description": "NM_004333.4(BRAF):c.1447A>C (p.Lys483Gln), ClinVar entry:https://www.ncbi.nlm.nih.gov/clinvar/variation/40369/\n\nAnother variant at the same residue (Lys483Asn) was identified as a de novo variant in an individual with features of a Noonan spectrum disorder (LMM unpublished data).\n\nThe other variant: NM_004333.4(BRAF):c.1449A>C (p.Lys483Asn) is classified as likely pathogenic by LMM for CFC and for Noonan Syndrome. Here is the ClinVar entry:\n\nhttps://www.ncbi.nlm.nih.gov/clinvar/variation/177878/\n\nThus, PM5 can be used for the p.Lys483Gln variant."
}
